Skip to content
2000
Volume 20, Issue 7
  • ISSN: 1574-8855
  • E-ISSN: 2212-3903

Abstract

Background

Type 2 Diabetes Mellitus (T2DM) is a prevalent metabolic disorder characterized by insulin resistance and hyperglycemia. Herbal remedies have been explored as alternative or adjunctive therapies for managing T2DM due to their perceived safety and potential antidiabetic properties.

Aims

This study aimed to provide a comprehensive examination of the current state of knowledge regarding herbal remedies for managing Type 2 Diabetes Mellitus (T2DM). It explored bioactive compounds in herbs implicated in glycemic control and evaluated their potential therapeutic effects on T2DM from both traditional and contemporary perspectives.

Objectives

The primary objectives of this in-depth study included scrutinizing the literature on herbal interventions for T2DM, identifying and evaluating the bioactive compounds in herbs implicated in glycemic control, assessing the mechanisms of action responsible for their antidiabetic properties, and investigating the safety profile and potential side effects associated with their use.

Methods

A systematic literature search was conducted across multiple databases, including PubMed, Scopus, and Web of Science. Articles published up to the present date, including peer-reviewed research articles, clinical trials, and systematic reviews, were considered for inclusion in this review.

Results and Discussion

The review presented a thorough analysis of herbal remedies commonly associated with T2DM management. Reductions in HbA1c levels and fasting blood glucose concentrations indicated that the investigated herbal medicines, including fenugreek, cinnamon, and bitter melon, have shown potential results in improving glycemic control in people with type 2 diabetes but more study is needed to verify their safety & effectiveness. The safety profile and possible adverse effects of herbal interventions are also addressed. While some herbs show promise in glycemic control, caution is advised in their use due to the limited number of high-quality clinical trials. The findings highlight the need for further research to validate the efficacy and safety of herbal remedies for T2DM.

Conclusion

The study provided valuable insights into the current understanding of herbal interventions for T2DM and underscored the importance of continued research in this field for the development of evidence-based therapeutic approaches.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdth/10.2174/0115748855307512240802043813
2024-10-06
2025-12-03

  • From This Site

    /content/journals/cdth/10.2174/0115748855307512240802043813
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Galicia-GarciaU. Benito-VicenteA. JebariS. Pathophysiology of type 2 diabetes mellitus.Int. J. Mol. Sci.20202117627510.3390/ijms21176275 32872570
     [Google Scholar]
  2. RahmanM.S. HossainK.S. DasS. Role of insulin in health and disease: an update.Int. J. Mol. Sci.20212212640310.3390/ijms22126403 34203830
     [Google Scholar]
  3. SamiW. AnsariT. ButtN.S. HamidM.R.A. Effect of diet on type 2 diabetes mellitus: A review.Int. J. Health Sci. (Qassim)20171126571[Qassim] 28539866
     [Google Scholar]
  4. O’RahillyS. BarrosoI. WarehamN.J. Genetic factors in type 2 diabetes: the end of the beginning?Science2005307570837037310.1126/science.1104346 15662000
     [Google Scholar]
  5. AtkinsonM.A. EisenbarthG.S. MichelsA.W. Type 1 diabetes.Lancet20143839911698210.1016/S0140‑6736(13)60591‑7 23890997
     [Google Scholar]
  6. RamachandranA. Know the signs and symptoms of diabetes.Indian J. Med. Res.20141405579581 25579136
     [Google Scholar]
  7. KhanM.A.B. HashimM.J. KingJ.K. GovenderR.D. MustafaH. Al KaabiJ. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends.J. Epidemiol. Glob. Health201910110711110.2991/jegh.k.191028.001 32175717
     [Google Scholar]
  8. MohanV. PradeepaR. Epidemiology of type 2 diabetes in India.Indian J. Ophthalmol.202169112932293810.4103/ijo.IJO_1627_21 34708726
     [Google Scholar]
  9. BetônicoC.C.R. TitanS.M.O. Correa-GiannellaM.L.C. NeryM. QueirozM. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.Clinics (São Paulo)2016711475310.6061/clinics/2016(01)08 26872083
     [Google Scholar]
  10. HaffnerS.M. Coronary heart disease in patients with diabetes.N. Engl. J. Med.2000342141040104210.1056/NEJM200004063421408 10749967
     [Google Scholar]
  11. BoultonA.J.M. MalikR.A. Diabetic neuropathy.Med. Clin. North Am.199882490992910.1016/S0025‑7125(05)70029‑8 9706126
     [Google Scholar]
  12. El AlamiH. HaddouI. BenaadiG. Prevalence and risk factors of chronic complications among patients with type 2 diabetes mellitus in Morocco: a cross-sectional study.Pan Afr. Med. J.2022411182 35655685
     [Google Scholar]
  13. AlqathamaA AlluhiabiG BaghdadiH Herbal medicine from the perspective of type II diabetic patients and physicians: what is the relationship?BMC comple med therap20202019
     [Google Scholar]
  14. HuiH. ZhaoX. PerfettiR. Structure and function studies of glucagon‐like peptide‐1 (GLP‐1): the designing of a novel pharmacological agent for the treatment of diabetes.Diabetes Metab. Res. Rev.200521431333110.1002/dmrr.553 15852457
     [Google Scholar]
  15. ModakM. DixitP. LondheJ. GhaskadbiS. DevasagayamT.P.A. Indian herbs and herbal drugs used for the treatment of diabetes.J. Clin. Biochem. Nutr.200740316317310.3164/jcbn.40.163 18398493
     [Google Scholar]
  16. KasoleR. MartinH.D. KimiyweJ. Traditional medicine and its role in the management of diabetes mellitus: “patients’ and herbalists’ perspectives”.Evid. Based Complement. Alternat. Med.2019201911210.1155/2019/2835691 31354852
     [Google Scholar]
  17. RaoM.U. SreenivasuluM. ChengaiahB. ReddyK.J. ChettyC.M. Herbal medicines for diabetes mellitus: a review.Int. J. Pharm. Tech. Res.20102318831892
     [Google Scholar]
  18. Sharifi-RadJ. RayessY.E. RizkA.A. Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications.Front. Pharmacol.2020110102110.3389/fphar.2020.01021 33041781
     [Google Scholar]
  19. YedjouC.G. GrigsbyJ. MbemiA. The management of diabetes mellitus using medicinal plants and vitamins.Int. J. Mol. Sci.20232410908510.3390/ijms24109085 37240430
     [Google Scholar]
  20. ParhamS. KharaziA.Z. Bakhsheshi-RadH.R. Antioxidant, antimicrobial and antiviral properties of herbal materials.Antioxidants2020912130910.3390/antiox9121309 33371338
     [Google Scholar]
  21. ChangC.L.T. LinY. BartolomeA.P. ChenY.C. ChiuS.C. YangW.C. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds.Evid. Based Complement. Alternat. Med.2013201313310.1155/2013/378657 23662132
     [Google Scholar]
  22. ShepherdP.R. KahnB.B. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.N. Engl. J. Med.1999341424825710.1056/NEJM199907223410406 10413738
     [Google Scholar]
  23. VieiraE. SherbuttK. ScanlanM. FrederickH. Non-pharmacological interventions to manage Type 2 diabetes in older hispanics: A systematic review.Innov. Aging20215Suppl. 197510.1093/geroni/igab046.3510
     [Google Scholar]
  24. AnilaL. HashimM.S. Evaluation of in vitro antidiabetic activity of methanolic extract of Ixora coccinea flowers.J Pharm Sci Res201911623672372
     [Google Scholar]
  25. ZhengY. LeyS.H. HuF.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.Nat. Rev. Endocrinol.2018142889810.1038/nrendo.2017.151 29219149
     [Google Scholar]
  26. LiuX. LiY. LiL. Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study.Sci. Rep.2016613142610.1038/srep31426 27510966
     [Google Scholar]
  27. SaeediP. PetersohnI. SalpeaP. MalandaB. KarurangaS. UnwinN. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract2019157107843
     [Google Scholar]
  28. RoglicG. WHO Global report on diabetes: A summary.Int. J. Noncommun. Dis.2016113810.4103/2468‑8827.184853
     [Google Scholar]
  29. ChoN.H. ShawJ.E. KarurangaS. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.Diabetes Res. Clin. Pract.201813827128110.1016/j.diabres.2018.02.023 29496507
     [Google Scholar]
  30. HuF.B. Globalization of Diabetes.Diabetes Care20113461249125710.2337/dc11‑0442 21617109
     [Google Scholar]
  31. World Health OrganizationGlobalization,Diets and Noncommunicable Diseases.Available from2003Available from: https://iris.who.int/bitstream/handle/10665/42609/9241590416.pdf?sequence=1(accessed on 7-7-2024)
     [Google Scholar]
  32. FoxA. FengW. AsalV. What is driving global obesity trends? Globalization or “modernization”?Global. Health20191513210.1186/s12992‑019‑0457‑y 31029156
     [Google Scholar]
  33. WilmotE. IdrisI. Early onset type 2 diabetes: risk factors, clinical impact and management.Ther. Adv. Chronic Dis.20145623424410.1177/2040622314548679 25364491
     [Google Scholar]
  34. RosenbloomA.L. JoeJ.R. YoungR.S. WinterW.E. Emerging epidemic of type 2 diabetes in youth.Diabetes Care199922234535410.2337/diacare.22.2.345 10333956
     [Google Scholar]
  35. CherneyK. Age of onset for type 2 diabetes: know your risk.2016Available from: https://www.healthline.com/health/type-2-diabetes-age-of-onset(accessed on 7-7-2024)
     [Google Scholar]
  36. Kautzky-WillerA. LeutnerM. HarreiterJ. Sex differences in type 2 diabetes.Diabetologia2023666986100210.1007/s00125‑023‑05891‑x 36897358
     [Google Scholar]
  37. CiarambinoT. CrispinoP. LetoG. MastrolorenzoE. ParaO. GiordanoM. Influence of gender in diabetes mellitus and its complication.Int. J. Mol. Sci.20222316885010.3390/ijms23168850 36012115
     [Google Scholar]
  38. MeoS.A. SheikhS.A. SattarK. Prevalence of type 2 diabetes mellitus among men in the Middle East: A retrospective study.Am. J. Men Health201913310.1177/1557988319848577 31055980
     [Google Scholar]
  39. SagastumeD. SieroI. MertensE. CottamJ. ColizziC. PeñalvoJ.L. The effectiveness of lifestyle interventions on type 2 diabetes and gestational diabetes incidence and cardiometabolic outcomes: A systematic review and meta-analysis of evidence from low- and middle-income countries.EClinicalMedicine20225310165010.1016/j.eclinm.2022.101650 36119561
     [Google Scholar]
  40. LinX. XuY. PanX. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.Sci. Rep.20201011479010.1038/s41598‑020‑71908‑9 32901098
     [Google Scholar]
  41. GoldenS.H. YajnikC. PhatakS. HansonR.L. KnowlerW.C. Racial/ethnic differences in the burden of type 2 diabetes over the life course: a focus on the USA and India.Diabetologia201962101751176010.1007/s00125‑019‑4968‑0 31451876
     [Google Scholar]
  42. NarayanK.M.V. KanayaA.M. Why are South Asians prone to type 2 diabetes? A hypothesis based on underexplored pathways.Diabetologia20206361103110910.1007/s00125‑020‑05132‑5 32236731
     [Google Scholar]
  43. UnnikrishnanR. PradeepaR. JoshiS.R. MohanV. Type 2 diabetes: demystifying the global epidemic.Diabetes20176661432144210.2337/db16‑0766 28533294
     [Google Scholar]
  44. LeonB.M. MaddoxT.M. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.World J. Diabetes20156131246125810.4239/wjd.v6.i13.1246 26468341
     [Google Scholar]
  45. DeshpandeA.D. Harris-HayesM. SchootmanM. Epidemiology of diabetes and diabetes-related complications.Phys. Ther.200888111254126410.2522/ptj.20080020 18801858
     [Google Scholar]
  46. ReutensAT PrenticeL AtkinsRC The epidemiology of diabetic kidney disease.Wiley Online library200810.1002/9780470779750.ch31
     [Google Scholar]
  47. O’ConnellJ.M. MansonS.M. Understanding the economic costs of diabetes and prediabetes and what we may learn about reducing the health and economic burden of these conditions.Diabetes Care20194291609161110.2337/dci19‑0017 31431494
     [Google Scholar]
  48. AfrozA. AlramadanM.J. HossainM.N. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.BMC Health Serv. Res.201818197210.1186/s12913‑018‑3772‑8 30558591
     [Google Scholar]
  49. SutradharI IkpemeM WeldegiorgisM Prevalence and control status of T2DM in Bangladesh: finding from a nationally representative survey.Eur J Public Health202131Suppl. 3ckab164.26210.1093/eurpub/ckab164.262
     [Google Scholar]
  50. AlareekiA. AwadS.F. CritchleyJ.A. Epidemiological impact of public health interventions against diabetes in Qatar: mathematical modeling analyses.Front. Public Health202311116780710.3389/fpubh.2023.1167807 37404285
     [Google Scholar]
  51. LiY. GuoC. CaoY. Secular incidence trends and effect of population aging on mortality due to type 1 and type 2 diabetes mellitus in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019.BMJ Open Diabetes Res. Care202192e00252910.1136/bmjdrc‑2021‑002529 34732399
     [Google Scholar]
  52. AndreozziF. CandidoR. CorraoS. Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review.Diabetol. Metab. Syndr.20201215210.1186/s13098‑020‑00559‑7 32565924
     [Google Scholar]
  53. Ab RahmanN. LimM.T. ThevendranS. Ahmad HamdiN. SivasampuS. Medication regimen complexity and medication burden among patients with type 2 diabetes mellitus: a retrospective analysis.Front. Pharmacol.20221380819010.3389/fphar.2022.808190 35387353
     [Google Scholar]
  54. Economic costs of diabetes in the US in 2017.Diabetes Care201841591792810.2337/dci18‑0007 29567642
     [Google Scholar]
  55. KahnS.E. The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of Type 2 diabetes.Diabetologia200346131910.1007/s00125‑002‑1009‑0 12637977
     [Google Scholar]
  56. KeC. NarayanK.M.V. ChanJ.C.N. JhaP. ShahB.R. Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations.Nat. Rev. Endocrinol.202218741343210.1038/s41574‑022‑00669‑4 35508700
     [Google Scholar]
  57. InaishiJ. SaishoY. B-cell mass in obesity and type 2 diabetes, and its relation to pancreas fat: a mini-review.Nutrients20201212384610.3390/nu12123846 33339276
     [Google Scholar]
  58. KabadiU.M. Major pathophysiology in prediabetes and type 2 diabetes: decreased insulin in lean and insulin resistance in obese.J. Endocr. Soc.20171674275010.1210/js.2016‑1116 29264527
     [Google Scholar]
  59. HasanzadeF. ToliatM. EmamiS.A. EmamimoghaadamZ. The effect of cinnamon on glucose of type II diabetes patients.J. Tradit. Complement. Med.20133317117410.4103/2225‑4110.114900 24716174
     [Google Scholar]
  60. GharibE. Montasser KouhsariS. Study of the antidiabetic activity of Punica granatum L. fruits aqueous extract on the alloxan-diabetic wistar rats. Iranian journal of pharmaceutical research.Iran. J. Pharm. Res.2019181358368 31089370
     [Google Scholar]
  61. SaishoY. An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to β cell-centric concept of diabetes - an Asian perspective.Expert Opin. Pharmacother.202021131565157710.1080/14656566.2020.1776262 32521177
     [Google Scholar]
  62. MassiminoE. IzzoA. RiccardiG. Della PepaG. The impact of glucose-lowering drugs on sarcopenia in type 2 diabetes: current evidence and underlying mechanisms.Cells2021108195810.3390/cells10081958 34440727
     [Google Scholar]
  63. StolarM. Glycemic control and complications in type 2 diabetes mellitus.Am. J. Med.20101233Suppl.S3S1110.1016/j.amjmed.2009.12.004 20206730
     [Google Scholar]
  64. IzundeguiD.G. NayorM. Metabolomics of type 1 and type 2 diabetes: insights into risk prediction and mechanisms.Curr. Diab. Rep.2022222657610.1007/s11892‑022‑01449‑0 35113332
     [Google Scholar]
  65. PezhmanL. TahraniA. ChimenM. Dysregulation of leukocyte trafficking in type 2 diabetes: mechanisms and potential therapeutic avenues.Front. Cell Dev. Biol.2021962418410.3389/fcell.2021.624184 33692997
     [Google Scholar]
  66. TaylorS.I. YazdiZ.S. BeitelsheesA.L. Pharmacological treatment of hyperglycemia in type 2 diabetes.J. Clin. Invest.20211312e14224310.1172/JCI142243 33463546
     [Google Scholar]
  67. TanD. TsengH.H.L. ZhongZ. WangS. VongC.T. WangY. Glycyrrhizic acid and its derivatives: promising candidates for the management of type 2 diabetes mellitus and its complications.Int. J. Mol. Sci.202223191098810.3390/ijms231910988 36232291
     [Google Scholar]
  68. TripathiP. PandeyA. PandeyR. SrivatavaR. GoswamiS. Alternative therapies useful in the management of diabetes: A systematic review.J. Pharm. Bioallied Sci.20113450451210.4103/0975‑7406.90103 22219583
     [Google Scholar]
  69. AsifM. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern.J. Educ. Health Promot.201431110.4103/2277‑9531.127541 24741641
     [Google Scholar]
  70. DaviesM.J. D’AlessioD.A. FradkinJ. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association [ADA] and the European Association for the Study of Diabetes.Diabetes Care201841122669270110.2337/dci18‑0033 30291106
     [Google Scholar]
  71. JenaB.N. KalraS. YeravdekarR. Emotional and psychological needs of people with diabetes.Indian J. Endocrinol. Metab.201822569670410.4103/ijem.IJEM_579_17 30294583
     [Google Scholar]
  72. GourgariE. WilhelmE.E. HassanzadehH. ArodaV.R. ShoulsonI. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.J. Diabetes Complications201731121719172710.1016/j.jdiacomp.2017.08.005 28939018
     [Google Scholar]
  73. KokilG.R. VeeduR.N. RammG.A. PrinsJ.B. ParekhH.S. Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics.Chem. Rev.2015115114719474310.1021/cr5002832 25918949
     [Google Scholar]
  74. ChaudhuryA. DuvoorC. Reddy DendiV.S. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management.Front. Endocrinol. (Lausanne)20178610.3389/fendo.2017.00006 28167928
     [Google Scholar]
  75. PolonskyW. HenryR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors.Patient Prefer. Adherence2016101299130710.2147/PPA.S106821 27524885
     [Google Scholar]
  76. MudaliarS. EdelmanS.V. Insulin therapy in type 2 diabetes.Endocrinol. Metab. Clin. North Am.200130493598210.1016/S0889‑8529(05)70222‑X 11727406
     [Google Scholar]
  77. SarbackerG.B. UrteagaE.M. Adherence to insulin therapy.Diabetes Spectr.201629316617010.2337/diaspect.29.3.166 27574371
     [Google Scholar]
  78. ButtM.D. OngS.C. WahabM.U. Cost of illness analysis of type 2 diabetes mellitus: the findings from a lower-middle income country.Int. J. Environ. Res. Public Health202219191261110.3390/ijerph191912611 36231911
     [Google Scholar]
  79. MoucheraudC. LenzC. LatkovicM. WirtzV.J. The costs of diabetes treatment in low- and middle-income countries: a systematic review.BMJ Glob. Health201941e00125810.1136/bmjgh‑2018‑001258 30899566
     [Google Scholar]
  80. SugandhF.N.U. ChandioM. RaveenaF.N.U. Advances in the management of diabetes mellitus: a focus on personalized medicine.Cureus2023158e4369710.7759/cureus.43697 37724233
     [Google Scholar]
  81. OngK.L. StaffordL.K. McLaughlinS.A. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.Lancet20234021039720323410.1016/S0140‑6736(23)01301‑6 37356446
     [Google Scholar]
  82. WangnooS. MajiD. DasA. Barriers and solutions to diabetes management: An Indian perspective.Indian J. Endocrinol. Metab.201317459460110.4103/2230‑8210.113749 23961474
     [Google Scholar]
  83. MohanV. VenkataramanK. KannanA.T. Challenges in diabetes management with particular reference to India.Int. J. Diabetes Dev. Ctries.200929310310910.4103/0973‑3930.54286 20165646
     [Google Scholar]
  84. TabishS.A. Complementary and alternative healthcare: is it evidence-based?Int. J. Health Sci. (Qassim)200821VIX [Qassim] 21475465
     [Google Scholar]
  85. BirdeeG.S. YehG. Complementary and alternative medicine therapies for diabetes: a clinical review.Clin. Diabetes201028414715510.2337/diaclin.28.4.147
     [Google Scholar]
  86. SheikhraboriA. DehghanM. GhaediF. KhademiG.R. Complementary and alternative medicine usage and its determinant factors among diabetic patients: an Iranian case.J. Evid. Based Complementary Altern. Med.201722344945410.1177/2156587216675079 27821612
     [Google Scholar]
  87. GrossmanL.D. RoscoeR. ShackA.R. GrossmanL.D. RoscoeR. ShackA.R. Complementary and alternative medicine for diabetes.Can. J. Diabetes201842Suppl. 1S154S16110.1016/j.jcjd.2017.10.023
     [Google Scholar]
  88. DhamS. ShahV. HirschS. BanerjiM.A. The role of complementary and alternative medicine in diabetes.Curr. Diab. Rep.20066325125810.1007/s11892‑006‑0042‑7 16898580
     [Google Scholar]
  89. KumarD. BajajS. MehrotraR. Knowledge, attitude and practice of complementary and alternative medicines for diabetes.Public Health2006120870571110.1016/j.puhe.2006.04.010 16828133
     [Google Scholar]
  90. FouladbakhshJ.M. BalneavesL. JenuwineE. Understanding CAM natural health products: implications of use among cancer patients and survivors.J. Adv. Pract. Oncol.20134528930610.6004/jadpro.2013.4.5.2 25032009
     [Google Scholar]
  91. BenzieI.F. Wachtel-GalorS. Herbal medicine: biomolecular and clinical aspects.Boca Raton (FL)CRC Press/Taylor and Francis201110.1201/b10787
     [Google Scholar]
  92. CassilethB.R. HeitzerM. WesaK. The public health impact of herbs and nutritional supplements.Pharm. Biol.200947876176710.1080/13880200902991581 19890479
     [Google Scholar]
  93. ChenC. LiuJ. SunM. LiuW. HanJ. WangH. Acupuncture for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.Complement. Ther. Clin. Pract.20193610011210.1016/j.ctcp.2019.04.004 31383426
     [Google Scholar]
  94. ChoE. KimW. Effect of acupuncture on diabetic neuropathy: a narrative review.Int. J. Mol. Sci.20212216857510.3390/ijms22168575 34445280
     [Google Scholar]
  95. RadwanH. HasanH. HamadehR. HashimM. Complementary and alternative medicine use among patients with type 2 diabetes living in the United Arab Emirates.BMC Complement. Med. Ther.2020201216
     [Google Scholar]
  96. KesavadevJ. SabooB. SadikotS. Unproven therapies for diabetes and their implications.Adv. Ther.2017341607710.1007/s12325‑016‑0439‑x 27864668
     [Google Scholar]
  97. ChangH. WallisM. TiralongoE. Use of complementary and alternative medicine among people living with diabetes: literature review.J. Adv. Nurs.200758430731910.1111/j.1365‑2648.2007.04291.x 17442034
     [Google Scholar]
  98. VentolaC.L. Current issues regarding complementary and alternative medicine [CAM] in the United States: part 1: the widespread use of CAM and the need for better-informed health care professionals to provide patient counseling.P&T2010358461468 20844696
     [Google Scholar]
  99. SaxenaB. The role of complementary and alternative medicines in the treatment and management of COVID-19.In: Complementary therapies.IntechOpen2021
     [Google Scholar]
  100. MedagamaA.B. BandaraR. The use of Complementary and Alternative Medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective?Nutr. J.201413110210.1186/1475‑2891‑13‑102 25331834
     [Google Scholar]
  101. VishnuN. MiniG.K. ThankappanK.R. Complementary and alternative medicine use by diabetes patients in Kerala, India.Glob. Health. Epidemiol. Genom.20172e610.1017/gheg.2017.6 29868217
     [Google Scholar]
  102. HoehnAN StockertAL The effects of Cinnamomum cassia on blood glucose values are greater than those of dietary changes alone.Nutrit metab insights20125NMI-S10498
     [Google Scholar]
  103. Avalos-SorianoA. De la Cruz-CorderoR. RosadoJ. Garcia-GascaT. 4-Hydroxyisoleucine from fenugreek (Trigonella foenum-graecum): effects on insulin resistance associated with obesity.Molecules20162111159610.3390/molecules21111596 27879673
     [Google Scholar]
  104. ZhuJ. ChenH. SongZ. WangX. SunZ. Effects of ginger (Zingiber officinale Roscoe) on type 2 diabetes mellitus and components of the metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.Evid. Based Complement. Alternat. Med.2018201811110.1155/2018/5692962 29541142
     [Google Scholar]
  105. MahwishSaeed F Sultan MT, et al. Bitter melon (Momordica charantia L.) fruit bioactives charantin and vicine potential for diabetes prophylaxis and treatment.Plants202110473010.3390/plants10040730 33918062
     [Google Scholar]
  106. ZhangD. FuM. GaoS.H. LiuJ.L. Curcumin and diabetes: a systematic review.Evid. Based Complement. Alternat. Med.2013201311610.1155/2013/636053 24348712
     [Google Scholar]
  107. DeoraN. VenkatramanK. Aloe vera in diabetic dyslipidemia: Improving blood glucose and lipoprotein levels in pre-clinical and clinical studies.J. Ayurveda Integr. Med.202213410067510.1016/j.jaim.2022.100675 36481618
     [Google Scholar]
  108. ChenW. BalanP. PopovichD.G. Review of ginseng anti-diabetic studies.Molecules20192424450110.3390/molecules24244501 31835292
     [Google Scholar]
  109. CaoC. SuM. Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome.Exp. Ther. Med.20191743009301410.3892/etm.2019.7295 30936971
     [Google Scholar]
  110. KatzD.L. DoughtyK. AliA. Cocoa and chocolate in human health and disease.Antioxid. Redox Signal.201115102779281110.1089/ars.2010.3697 21470061
     [Google Scholar]
  111. JamshidiN. CohenM.M. The clinical efficacy and safety of tulsi in humans: a systematic review of the literature.Evid. Based Complement. Alternat. Med.2017201711310.1155/2017/9217567 28400848
     [Google Scholar]
  112. BashshurR.L. ShannonG.W. SmithB.R. WoodwardM.A. The empirical evidence for the telemedicine intervention in diabetes management.Telemed. J. E Health201521532135410.1089/tmj.2015.0029 25806910
     [Google Scholar]
  113. KootiW. FarokhipourM. AsadzadehZ. Ashtary-LarkyD. Asadi-SamaniM. The role of medicinal plants in the treatment of diabetes: a systematic review.Electron. Physician2016811832184210.19082/1832 26955456
     [Google Scholar]
  114. HuangF. DengT. MengL. MaX. Dietary ginger as a traditional therapy for blood sugar control in patients with type 2 diabetes mellitus.Medicine (Baltimore)20199813e1505410.1097/MD.0000000000015054 30921234
     [Google Scholar]
  115. RamosS. MartínM. GoyaL. Effects of cocoa antioxidants in type 2 diabetes mellitus.Antioxidants2017648410.3390/antiox6040084 29088075
     [Google Scholar]
  116. PeaceHealthHoly Basil.Available From: https://www.peacehealth.org/medical-topics/id/hn-4597000 (accessed on 7-7-2024)
     [Google Scholar]
  117. PangG.M. LiF.X. YanY. Herbal medicine in the treatment of patients with type 2 diabetes mellitus.Chin. Med. J. (Engl.)20191321788510.1097/CM9.0000000000000006 30628962
     [Google Scholar]
  118. KleinS. GastaldelliA. Yki-JärvinenH. SchererP.E. Why does obesity cause diabetes?Cell Metab.2022341112010.1016/j.cmet.2021.12.012 34986330
     [Google Scholar]
  119. AmirehsaniK.A. HuJ. WallaceD.C. McCoyT.P. Herbal/plant remedies and supplements used by hispanics/latinxs for diabetes: source of functional foods?Science of Diabetes Self Management and Care20214719410410.1177/0145721720983221 34078206
     [Google Scholar]
  120. XieW. ZhaoY. ZhangY. Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus.Evid. Based Complement. Alternat. Med.201120111310.1155/2011/726723
     [Google Scholar]
  121. SallehN.H. ZulkipliI.N. Mohd YasinH. Systematic review of medicinal plants used for treatment of diabetes in human clinical trials: an ASEAN perspective.Evid. Based Complement. Alternat. Med.2021202111010.1155/2021/5570939 34691218
     [Google Scholar]
  122. ChackoE. Culture and therapy: complementary strategies for the treatment of type-2 diabetes in an urban setting in Kerala, India.Soc. Sci. Med.20035651087109810.1016/S0277‑9536(02)00105‑3 12593880
     [Google Scholar]
  123. ZhangX. ZhangL. ZhangB. Herbal tea, a novel adjuvant therapy for treating type 2 diabetes mellitus: A review.Front. Pharmacol.20221398238710.3389/fphar.2022.982387 36249806
     [Google Scholar]
  124. GraffignaG. BarelloS. LibreriC. BosioC.A. How to engage type-2 diabetic patients in their own health management: implications for clinical practice.BMC Public Health201414164810.1186/1471‑2458‑14‑648 24966036
     [Google Scholar]
  125. Type 2 diabetes mellitus with obesity and dyslipidemia treated by Chinese herbal medicine.Patent NCT050729902021
  126. Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.Patent NCT057604562023
  127. Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics.Patent NCT041202592019
  128. Efficacy assessment of Chinese herbal medicine Jiangtang Tiaozhi recipe treating participants with glucose and lipid metabolism disturbances. Patent NCT046235672020
  129. Chickpea Pulao Using Fenugreek Seeds and Indian Rennet for Improving Blood Glycaemic Levels.Patent NCT060956222023
  130. Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms. Patent NCT018440502019
  131. Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients.Patent NCT050815832021
  132. LiuWeiLuoBi Granule for the Treatment of Diabetic Peripheral Neuropathy. Patent NCT044575312020
  133. Safety and efficacy of herbal tea in Type 2 diabetics. Patent NCT040542842019
  134. Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM. Patent NCT022892352014
  135. The Hypoglycemic Effect of Cyclocarya Paliurus Extract on Hyperglycemic Populations. Patent NCT041844402019
/content/journals/cdth/10.2174/0115748855307512240802043813
Loading
Herbal Remedies for Type 2 Diabetes Mellitus: An Explicit Review
Curr Drug Ther 20, 1034 (2025); https://doi.org/10.2174/0115748855307512240802043813
/content/journals/cdth/10.2174/0115748855307512240802043813
/content/journals/cdth/10.2174/0115748855307512240802043813
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): antidiabetic properties; bioactive compounds; glycemic control; Herbal remedies; natural remedies; Type-2 diabetes mellitus

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test